Integrin αIIb (CD41) plays a role in the maintenance of hematopoietic stem cell activity in the mouse embryonic aorta by Boisset, Jean-Charles et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Integrin IIb (CD41) plays a role in the maintenance of
hematopoietic stem cell activity in the mouse embryonic aorta
Citation for published version:
Boisset, J-C, Clapes, T, Van Der Linden, R, Dzierzak, E & Robin, C 2013, 'Integrin IIb (CD41) plays a role in
the maintenance of hematopoietic stem cell activity in the mouse embryonic aorta' Biology Open, vol. 2, no.
5, pp. 525-32. DOI: 10.1242/bio.20133715
Digital Object Identifier (DOI):
10.1242/bio.20133715
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Biology Open
Publisher Rights Statement:
    © 2013. Published by The Company of Biologists Ltd
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial
Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0/).
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Integrin aIIb (CD41) plays a role in the maintenance of
hematopoietic stem cell activity in the mouse
embryonic aorta
Jean-Charles Boisset*, Thomas Clapes*, Reinier van der Linden, Elaine Dzierzak and Catherine Robin*,`
Erasmus University Medical Center, Department of Cell Biology, Erasmus MC Stem Cell Institute, PO Box 2040, 3000 CA Rotterdam,
The Netherlands
*Present address: Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands
`Author for correspondence (c.robin@hubrecht.eu)
Biology Open 2, 525–532
doi: 10.1242/bio.20133715
Received 22nd November 2012
Accepted 20th March 2013
Summary
Integrins are transmembrane receptors that play important
roles as modulators of cell behaviour through their adhesion
properties and the initiation of signaling cascades. The aIIb
integrin subunit (CD41) is one of the first cell surface
markers indicative of hematopoietic commitment. aIIb pairs
exclusively with b3 to form the aIIbb3 integrin. b3 (CD61) also
pairs with av (CD51) to form the avb3 integrin. The expression
and putative role of these integrins during mouse
hematopoietic development is as yet unknown. We show
here that hematopoietic stem cells (HSCs) differentially
express aIIbb3 and avb3 integrins throughout development.
Whereas the first HSCs generated in the aorta at mid-
gestation express both integrins, HSCs from the placenta only
express avb3, and most fetal liver HSCs do not express either
integrin. By using aIIb deficient embryos, we show that aIIb is
not only a reliable HSC marker but it also plays an important
and specific function in maintaining the HSC activity in the
mouse embryonic aorta.
 2013. Published by The Company of Biologists Ltd. This is
an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial Share Alike
License (http://creativecommons.org/licenses/by-nc-sa/3.0).
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Introduction
Hematopoietic stem cells (HSCs) are at the foundation of the blood
system and are the key cell type in transplantation protocols for
blood-related disorders. The number of HSCs available for clinical
applications and fundamental research is limited. The efficient
expansion and/or generation in vitro is thus far not possible
because our knowledge of the mechanisms underlying HSC
growth, including the specific in vivo interactions between HSCs
and the surrounding microenvironment are poorly understood.
Adult HSCs are generated only during a short window of
developmental time (Boisset and Robin, 2012). They are first
detected at embryonic day (E)10.5 of mouse development in the
Aorta–Gonad–Mesonephros (AGM) region (Medvinsky and
Dzierzak, 1996; Mu¨ller et al., 1994). Starting at E11, HSCs are
also found in the yolk sac (YS), placenta (PL) and fetal liver
(FL). The pool of HSCs expands in the PL and FL before
colonizing the bone marrow (BM) from E17 onward (Gekas et
al., 2005; Ottersbach and Dzierzak, 2005). Studies performed in
the zebrafish, chicken and mouse models have clearly
demonstrated that HSCs originate from specialized endothelial
cells referred as hemogenic (Boisset and Robin, 2012). HSCs
most likely reside in clusters of cells (Intra-Aortic Hematopoietic
Clusters, IAHCs) that are tightly attached to the endothelium of
the aorta, the vitelline and umbilical arteries, and the vascular
labyrinth of the placenta (Rhodes et al., 2008; Yokomizo and
Dzierzak, 2010). In adult BM, HSCs localize in specialized
niches that maintain the balance between HSC self-renewal,
quiescence and differentiation. Adhesion molecules (including
integrins) are important for the binding of HSCs to the BM niches
(Grassinger et al., 2009; Notta et al., 2011; Potocnik et al., 2000;
Qian et al., 2006; Umemoto et al., 2006; Wagers and Weissman,
2006). In contrast to adult, the specific interactions and cell
adhesion properties of HSCs in the aorta and the successive
developmental niches are as yet poorly described.
Integrins are transmembrane glycoproteins (gp) that play an
important role in cell adhesion, survival, proliferation,
differentiation, migration, gene regulation, and cytoskeletal
arrangement. They are a family of 24 heterodimeric receptors
composed of a (18 types) and b (8 types) subunits (Prowse et al.,
2011). While some integrins are ubiquitously expressed, others
are tissue- or cell lineage-specific (Bouvard et al., 2001). Adult
HSCs express several integrins important for homing and
migration (e.g. a4b1, a5b1, a6b1) (Bonig et al., 2009a; Bonig et
al., 2009b; Grassinger et al., 2009; Lapidot et al., 2005). In the
embryo, aIIb (platelet (gp)IIb or CD41) is one of the earliest
surface markers of hematopoietic commitment (Emambokus and
Frampton, 2003; Ferkowicz et al., 2003; McKinney-Freeman et
al., 2009; Mikkola et al., 2003; Mitjavila-Garcia et al., 2002;
Robin et al., 2011) and its expression is developmentally
regulated. E11 AGM HSCs express aIIb, whereas HSCs in the
E12 AGM, E12 PL or E14 FL are aIIb negative (Matsubara et al.,
2005; McKinney-Freeman et al., 2009; Robin et al., 2011). By
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performing time-lapse confocal imaging on live mouse embryo
slices, we have shown that the onset of aIIb expression coincides
with the formation of hematopoietic stem/progenitor cells
(HSPCs) from the hemogenic aortic endothelium (Boisset et
al., 2011; Boisset et al., 2010) and that aIIb protein localizes at the
point of contact between the cells in IAHCs.
To date little is known about integrin function and expression
in HSCs throughout development. The BM of aIIb deficient mice
show no hematopoietic lineage commitment problems (Tronik-
Le Roux et al., 2000) but possess defective platelets and display
bleeding disorders similar to those seen in b3 deficient mice
(Hodivala-Dilke et al., 1999) and humans with Glanzmann
thrombasthenia disease. Here we examine the expression of aIIb,
b3 and av integrin subunits on HSCs in the main hematopoietic
sites (AGM, YS, PL, and FL) and the function of aIIb in these
cells. aIIb exclusively associates with b3 to form the major
platelet integrin aIIbb3 (gpIIb/IIIa or CD41/CD61). b3 also
associates with av to form the avb3 integrin (CD51/CD61). We
show by performing in vivo transplantation assays of sorted
populations that newly generated E11 AGM HSCs express aIIbb3
integrins whereas HSCs from E12 PL and E14 FL do not. avb3 is
expressed on all AGM and PL HSCs but on only a few E14 FL
HSCs. All three types of HSCs were found in the E12 YS.
Interestingly, aIIb deficient embryos show an HSC defect in the
AGM but not in the YS and FL, indicating that aIIb plays a
fundamental and precise spatio-temporal role to maintain the
HSC activity in the aorta of the mouse embryo.
Materials and Methods
Mice and embryo generation
Embryos were generated from crosses of hb-globin ln72 mice and wild-type
(C57BL/106CBA)F1 females; Ly5.1 males and females; aIIb
+/tk males and aIIb
+/+
or aIIb
+/tk females; aIIb
tk/tk males and aIIb
+/+ or aIIb
+/tk females; wild-type C57BL/6
females and males. The day of vaginal plug observation is embryonic day (E)0.
ln72, YMT and aIIb genotypes were determined by DNA PCR. Mice were housed
according to institutional guidelines and all animal procedures were carried out in
compliance with the Standards for human care and use of laboratory animals.
Dissections and cell preparation
E11–E14 embryos were isolated. Tissues (AGM, FL, YS, PL) were dissected and
dissociated as previously described (Robin and Dzierzak, 2005). Viable cells were
counted (using trypan blue) and kept in phosphate-buffered saline (PBS), 10% fetal
calf serum, and penicillin/streptomycin (PBS/FCS/PS) at 4 C˚ for further analysis.
Explant culture
Whole AGMs were cultured as explants at 37 C˚ for 3 days as previously described
(Medvinsky and Dzierzak, 1996). Explant cultures of aIIb mutant AGMs were
performed with no added cytokines. To test the number of CD41intCD61intCD45intc-
kit+ cells per wild-type AGM, the medium was supplemented or not with 200 ng/ml
of recombinant murine IL-3 (Robin et al., 2006) or 250 ng/ml of gremlin (Durand et
al., 2007).
Hematopoietic progenitor assay
In vitro hematopoietic progenitor analysis was performed on dilutions of sorted
cells plated in triplicates in methylcellulose medium (StemCell Technologies).
Plates were incubated at 37 C˚ in a humidified chamber under 5% CO2.
Hematopoietic colonies were counted with an inverted microscope at day 12 of
the culture.
In vivo transplantation assay and transplanted mice analysis
Intravenous injection of total or sorted cells into irradiated adult wild-type
recipients was as previously described (Robin et al., 2006). Recipient female mice
((129/SV6C57BL/6), C57BL/6 or (CBA6C57BL/10)) were exposed to a split
dose of 9 Gy of c-irradiation (137Cs source) and injected with several cell doses (or
embryo equivalent, ee). 26105 spleen cells (recipient background) were co-
injected to promote short-term survival.
Blood was obtained at 1 and 4 months post-transplantation and DNA was
analyzed for donor cell markers by semiquantitative PCR (hb-globin, aIIb, Ymt).
The percentage of donor contribution was calculated from a standard curve of
DNA control dilutions (0 to 100% donor marker). Recipients were considered
repopulated when the chimerism was greater than 10%. For multilineage
repopulation analysis, thymus, lymph nodes, bone marrow and spleen were
dissected from the repopulated recipients. T, B, erythroid, and myeloid cells were
sorted from recipient BM and spleens after antibody staining (see below). Primary
recipient BM cells were injected into secondary irradiated recipients to assess self-
renewal capacity (0.56106 or 26106 cells injected per recipient; supplementary
material Fig. S4D). Chimerism level of the Ly5.2 recipients (C57BL/6) injected
with Ly5.1 cells was determined by flow cytometry (see below). Recipients were
considered repopulated when the chimerism was greater than 5%.
For statistical analysis, student’s t test (Mann–Whitney) was used to determined
statistical significance.
Flow cytometric analysis and sorting
Flow cytometric analysis and sorting were performed on a FACScan and/or AriaIII
(BD Bioscience) with CellQuest and FACSDiva. Stainings were performed in
PBS/FCS/PS for 30 min at 4 C˚. Cells were washed and resuspended in PBS/FCS/
PS and 7-AAD (Molecular Probes, Leiden, NL) or Hoechst 33258 (1 mg/ml,
Molecular Probes) for dead cell exclusion. The positive gates were defined from
staining with isotype-matched control antibodies. Monoclonal antibodies (BD
Pharmingen, eBioscience, Invitrogen, Santa Cruz, Biolegends) used: FITC-anti-
Ter119, FITC-anti-CD42c (Gp1bb); PE-anti-CD41; APC-anti-CD61; FITC, APC-
Cy7 or APC-AlexaFluor750-anti-c-kit; FITC, PE or PE-Cy7-anti-CD31; PerCP-
Cy5.5-anti-CD45; APC or Pacific Blue-anti-CD34; Alexa-Fluor488-anti-CD51;
Lin cocktail (PE-anti-Ter119, PE-anti-B220, PE-anti-Mac1, PE-anti-Gr1, PE-anti-
CD3e); PE-anti-CD48; APC-anti-CD150 and PE-Cy7-anti-Sca-1.
Ly5.2/Ly5.1 cell chimerism was determined by flow cytometry on blood after
erythrocyte lysis (Beckman Coulter) and staining with FITC-anti-Ly5.2, PE-anti-
Ly5.1 and 7-AAD. Flow cytometry data were analyzed with FlowJo.
For multilineage repopulation analysis, spleen cells were stained with FITC-
anti-B220, PE-anti-CD8a and PE-anti-CD4; bone marrow cells were stained with
FITC-anti-Ly6C and PE-anti-CD31.
Cell cycle analysis
Cells from dissociated E11 AGM were stained with PE-anti-c-kit antibody. Cells
were washed prior to fixation with 2% PFA for 30 min. Cells were then
permeabilized for 1 h in 0.2% Triton X-100. After washing, cells were incubated
during 1 h with FITC-anti-Ki-67 antibody or IgG isotype control. Cells were
washed and incubated with Hoechst 33342 (1 mg/ml, Molecular Probes) prior to
analysis by flow cytometry.
Pre-apoptosis analysis
Cells from dissociated E11 AGM were stained with PE-anti-c-kit antibody. Cells
were washed in cold PBS and resuspended in 16 binding buffer (10 mM Hepes/
NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) and stained for 20 min with
Annexin-V-FITC and Hoechst 33258 (1 mg/ml, Molecular Probes). Analyses were
performed within 1 h by flow cytometry.
Whole-mount immunostaining
The whole-mount immunostaining was performed as previously described
(Yokomizo and Dzierzak, 2010). Rat anti-mouse primary antibodies for c-Kit
(2B8) and biotinylated anti-CD31 (MEC13.3) were used (BD Biosciences).
Secondary antibodies were goat anti-rat IgG-Alexa647 (Invitrogen) and
streptavidin-Alexa594 (Invitrogen). Embryo caudal halves were imaged using a
Leica SP5 confocal microscope.
Staining and confocal microscopy of non-fixed embryo and
placenta slices
Non-fixed wild-type embryos were cut into thick transversal slices (200 mm) and stained
with directly conjugated monoclonal antibodies as previously described (Boisset et al.,
2011; Boisset et al., 2010). The antibodies include: PE-anti-CD41 (MWreg30),
Alexa488-anti-CD51 (RMV-7), APC-anti-CD61. Similarly, placentas isolated from E12
non-fixed wild-type embryos were cut into slices (200 mm) and were incubated with
PE-anti-Tie-2, Alexa488-anti-CD51 (RMV-7) and APC-anti-CD61. Slices were
immobilized into agarose gel and imaged by using a Leica SP5 confocal microscope.
Results
Hematopoietic stem cells differentially express aIIbb3 and avb3
integrins throughout development
HSCs are restricted to the CD41intermediate (CD41int) fraction in
E11 AGM (McKinney-Freeman et al., 2009; Robin et al., 2011).
However, HSCs in E12 AGM and PL, and E14 FL are
exclusively in the CD412 fraction. In YS, HSCs are in both
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populations (Robin et al., 2011). To further investigate integrin
subunit expression on HSCs, we performed flow cytometric
analyses for av (CD51) and b3 (CD61), in addition to aIIb (CD41)
expression. Cells were analysed at the time points corresponding
to organ-specific peaks of HSC activity and subunit expression
was found to differ between tissues (Fig. 1). CD41intCD612 cells
were found only in E11 AGM (Fig. 1A), and not in E12 YS
(Fig. 1C), E12 PL (Fig. 1E) or E14 FL (Fig. 1G).
CD412CD61high cells were found mainly in E12 PL (Fig. 1E)
and to a lesser extent in E11 AGM (Fig. 1A). Three distinct cell
populations were present in all tissues: CD412CD612,
CD412CD61int and CD41intCD61int.
To determine whether HSCs in E11 AGM expressed both aIIb
and b3 subunits, CD41
intCD612 and CD41intCD61int fractions
were sorted and injected into adult wild-type irradiated recipients
(n52 (n5independent experiments when not specified
otherwise)). Four months post-transplantation, the mice injected
with CD41intCD61int cells were reconstituted (5 mice
reconstituted out of 6 mice transplanted, 5/6). No mice (0/8)
injected with CD41intCD612 cells were reconstituted, even with
a high cell dose (3 ee per mouse) (Fig. 1B). High-level
multilineage engraftment of blood, BM, spleen, lymph nodes
and thymus was found in the recipients receiving CD41intCD61int
cells (supplementary material Fig. S1, top panel) and secondary
recipients were successfully engrafted with BM from these
primary recipients, thus demonstrating that the CD41intCD61int
population contains bona fide HSCs (supplementary material Fig.
S1, bottom panel). 95% of the CD41intCD61int cells also
expressed CD51 (Table 1). At E12, AGM HSCs were CD412
(Robin et al., 2011) but still expressed CD51 (Table 1). Thus, all
HSCs in E11 AGM express both aIIbb3 and avb3 integrins.
YS HSCs are both CD412 and CD41int at E11 and E12 (Robin
et al., 2011). In combination with CD61, three cell fractions were
sorted from E12 YS (CD412CD612, CD412CD61int and
Fig. 1. Phenotypic and functional analyses of
integrin-based sorted cell fractions. (A,C,E,G)
Flow cytometric analyses of E11 Aorta–Gonad–
Mesonephros (AGM), E12 yolk sac (YS), E12
placenta (PL) and E14 fetal liver (FL).
Representative sorting gates of each population
are indicated. (B,D,F,H) Hematopoietic
repopulation analyses after injection of integrin-
based sorted fractions of AGM (n52), YS
(n54), PL (n52) and FL (n53). Numbers above
columns indicate number of mice repopulated/
number of mice injected. Dose of injected cells
is indicated as embryo equivalent (ee).
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CD41intCD61int) (Fig. 1C) and transplanted (n54). Multilineage
engraftment was obtained with all fractions (Fig. 1D). Similar to
E11 AGM HSCs, YS cells in the CD41intCD61int and
CD412CD61int fractions expressed CD51 (97% and 72%
respectively) (Table 1). On the other hand, the majority of
CD412CD612 cells did not express CD51 (Table 1). Thus, YS
and AGM contain HSCs that express both aIIbb3 and avb3
integrins, whereas some YS HSCs express solely avb3 integrin or
none of these integrins.
HSCs in PL and FL are CD412 (Robin et al., 2011).
CD412CD612, CD412CD61int and CD412CD61high (only
present in PL) fractions were sorted (Fig. 1E,G) and
transplanted (PL: n52, FL: n53). The PL CD412CD61int
fraction (but not the CD412CD612 fraction) contained HSCs
(Fig. 1F). Most of CD412CD61int cells expressed CD51 (86%)
(Table 1). Thus, CD412CD61int HSCs in PL express only avb3
integrin and therefore resemble CD412CD61int YS HSCs. In E14
FL, HSCs were in both CD412CD612 and CD412CD61int
fractions (Fig. 1H). Limiting cell dilution transplantations (0.001
to 0.1 ee) showed that HSCs were enriched in the CD412CD612
fraction (Fig. 1H). Similar to E12 PL and YS, CD412CD61int FL
cells also expressed CD51 (98%) (Table 1). In contrast,
CD412CD612 FL cells did not express CD51 (Table 1). Thus,
all HSCs in the PL express avb3 but not aIIbb3 integrins, whereas
most FL HSCs do not express these integrins.
E11 AGM hematopoietic stem cells are enriched in the
CD41intCD61intCD45intc-kit+ subpopulation
Further enrichment of the E11 AGM CD41intCD61int population
was attempted with the pan-hematopoietic marker CD45 and the
HSC marker c-kit (Sa´nchez et al., 1996). All committed cells
from erythroid (Ter119+) and megakaryocytic (Gp1bb+) lineages
were first excluded (supplementary material Fig. S2A, left panel)
and the CD41intCD61int HSC containing fraction (Fig. 1A,B) was
sorted into four subfractions: CD452c-kit2, CD452c-kit+,
CD45intc-kit+ and CD45highc-kit+ (supplementary material Fig.
S2A, middle and right panels). Cells were injected into irradiated
adult recipients and engraftment was measured at 1 month (short-
term repopulation, STR) and 4 months (long-term repopulation,
LTR) post-transplantation (n58). As expected, the CD452c-kit2
and CD452c-kit+ subfractions yielded no repopulation, even with
high doses of injected cells (5–10 ee) (supplementary material
Fig. S2C). The CD45intc-kit+ and CD45highc-kit+ subfractions
yielded short-term repopulation (supplementary material Fig.
S2C, left panel), but only the CD45intc-kit+ subfraction was
capable of long-term repopulation (supplementary material Fig.
S2C, right panel). These cells provided high-level multilineage
reconstitution of the primary and secondary transplanted
recipients (supplementary material Fig. S2B). Thus, the
CD41intCD61int population contains both STR-HSCs and LTR-
HSCs that both express CD45 and c-kit. However, STR-HSCs
and LTR-HSCs can be discriminated based on the level of CD45
expression: STR-HSCs are CD45high while LTR-HSCs are
CD45int. There is as few as 96631 CD41intCD61intCD45intc-
kit+ cells per E11 AGM (n56). Thus, the combination of integrin
expression with other hematopoietic markers such as CD45 and
c-kit can be used to discriminate cell populations highly enriched
in STR-HSCs and LTR-HSCs in E11 AGM.
Interestingly, the number of CD41intCD61intCD45intc-kit+ cells
per AGM was increased when E11 AGM explants were cultured in
the presence of IL-3 and decreased in the presence of Gremlin, as
compared to non-supplemented controls (supplementary material
Fig. S2D,E). This is consistent with our previous findings that IL-3
is a powerful amplifying factor (Robin et al., 2006) and Gremlin (a
BMP antagonist) is an inhibitory factor for HSC activity in E11
AGM (Durand et al., 2007; Robin and Durand, 2010). Therefore,
the refined CD41intCD61intCD45intc-kit+ HSC phenotype provides
a rapid readout for testing the effects of specific molecules/
reagents in AGM and perhaps other embryonic culture systems.
Localization of aIIb, av and/or b3 integrin subunits expressing
cells in the AGM and placenta
To determine the precise location of cells expressing aIIb, av and/or
b3, multicolour stainings were performed using the technique that
we previously developed to stain non-fixed embryo slices (Boisset
et al., 2011). We observed CD41intCD51intCD61int cells in the
IAHCs of E10.5 embryos (Fig. 2A). Interestingly, the integrin
subunits were concentrated at the junction between the IAHC cells.
The embryo slice staining technique was adapted to non-fixed
PL. E12 PL slices stained with directly labelled
Table 1. Percentage of CD51+ cells in the cell fractions
enriched in hematopoietic stem cells.
Tissue Embryonic day Cell fraction
Percentage of CD51+
cells in the cell fraction
AGM E11 CD41intCD61int 95
E12 CD412 96
Placenta E12 CD412CD61int 86
YS E12 CD41intCD61int 97
CD412CD61int 72
CD412CD612 34
FL E14 CD412CD61int 98
CD412CD612 8
Fig. 2. Location of phenotypically defined HSCs in AGM and placenta.
(A) Intra-aortic hematopoietic clusters (IAHCs) of E10.5 wild-type embryos. Non-
fixed embryo slices were stained with antibodies against CD51 (av), CD41 (aIIb)
and CD61 (b3). Scale bars: 10 mm. (B) Non-fixed placenta slices (E12) were
stained with antibodies against Tie-2. Transmitted light and fluorescent images are
merged. Scale bar: 100 mm. (C) Confocal stack image of an E12 non-fixed placenta
slice stained with antibodies against CD51, CD61 and Tie-2. Close up of the boxed
area (left panel) shows a group of labelled cells (single and merged fluorescent
channels are shown). Scale bars: 10 mm. UA: umbilical artery, C: chorionic plate,
L: labyrinth, S: spongiotrophoblast layer, FV: fetal vessel.
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anti-Tie-2 antibodies (Fig. 2B) showed specific staining of both
placental vessels and umbilical artery (UA). This allowed
discrimination of the chorionic plate (C), the vascular labyrinth
(L) and the spongiotrophoblast layer (S) (Fig. 2B). To localize
phenotypically defined HSCs in the Tie-2+ placental vessels
(FV), multicolour staining was performed with anti-CD51 and
CD61 antibodies (Fig. 2C). Groups of CD51intCD61int cells were
observed in the vasculature of the chorionic plate and similar to
the aorta, the integrin subunits were concentrated at the junctions
between cells (Fig. 2C). Thus, integrin expressing HSCs are
localized in the IAHCs as well as in the vasculature of the
placental chorionic plate.
aIIb deficient embryos have no qualitative or quantitative defects
in AGM hematopoietic progenitors or IAHCs
All hematopoietic progenitors are CD41int in the E11 AGM
(Robin et al., 2011). To test whether aIIb plays a role in the
production of hematopoietic progenitors, AGM cells from E11
wild-type (aIIb
+/+) and aIIb mutant (aIIb
+/tk and aIIb
tk/tk) embryos
(Tronik-Le Roux et al., 2000) were isolated and tested in the
colony forming unit-culture assay (CFU-C; n53). As shown in
Fig. 3A, AGMs of E11 mutant embryos contained erythroid and
myeloid progenitors. The numbers of total CFU-C and of each
type of progenitor were similar in the mutants as compared to
wild-type AGMs, demonstrating that aIIb does not influence the
production or function of AGM progenitors.
Whole embryo imaging of aIIb
+/+, aIIb
+/tk and aIIb
tk/tk E11
embryos immunostained for CD31 (to visualize endothelial and
IAHC cells) and c-kit (to visualize IAHC cells) revealed no
differences in IAHC cell number (Fig. 3B), organization or shape
(Fig. 3C,D). To investigate whether the lack of aIIb affects the
expression of av (CD51) and b3 (CD61), we performed flow
cytometric analysis on aIIb
+/+, aIIb
+/tk and aIIb
tk/tk E11 AGMs
(supplementary material Fig. S3). CD51 and CD61 expression
levels were similar between the different phenotypes, although
the CD51+CD61high population was absent in the aIIb
tk/tk AGMs.
Thus, the absence of CD41 does not influence expression of
CD51 and CD61. Together, these results show that aIIb is not
needed for the formation, organization and anchorage of IAHCs,
or there is functional redundancy with other integrins/adhesion
molecules (e.g. avb3).
aIIb deficient embryos have a hematopoietic stem cell defect in
the AGM
To test whether aIIb plays a role in the function of AGM HSCs,
transplantations were performed with cells isolated from E11
wild-type (aIIb
+/+) and aIIb mutant (aIIb
+/tk and aIIb
tk/tk) AGMs
(n53). Whereas 72% of the mice injected with aIIb
+/+ cells were
reconstituted, only 29% and 38% of mice were reconstituted with
aIIb
+/tk or aIIb
tk/tk cells, respectively, at four months post-
transplantation (Fig. 4A). The percentage of donor cell
chimerism was significantly lower in the few mice repopulated
with aIIb
+/tk or aIIb
tk/tk cells (10% average) as compared to the
mice injected with aIIb
+/+ cells (60% average) (Fig. 4A, red
bars). The reconstitution with aIIb
tk/tk cells resulted in
multilineage engraftment (supplementary material Fig. S4B,C)
similar to that found in mice reconstituted with aIIb
+/+ cells
(supplementary material Fig. S4A). Secondary transplantations of
BM cells (two cell doses, supplementary material Fig. S4D,E)
isolated from two primary recipients repopulated with aIIb
tk/tk
AGM HSCs and one recipient repopulated with aIIb
+/+ cells
(Fig. 4A, red lozenges; supplementary material Fig. S4A,B,C)
showed that aIIb
tk/tk AGM HSCs were self-renewing. aIIb
tk/tk
AGM-derived cells successfully repopulated secondary recipients
with similar chimerism as aIIb
+/+ AGM-derived cells
(supplementary material Fig. S4D,E). Thus, although aIIb
+/tk
and aIIb
tk/tk embryos have fewer HSCs in the AGM as compared
to aIIb
+/+ embryos, these are fully functional HSCs.
It was previously shown that the number of HSCs increases
when AGMs are cultured as explants for 3 days (Medvinsky and
Fig. 3. Intra-aortic hematopoietic clusters and in
vitro clonogenic progenitor activity of AGM cells
isolated from E11 CD41 (aIIb) deficient embryos.
(A) In vitro clonogenic analyses. AGMs were isolated
from E11 wild-type (aIIb
+/+), heterozygous (aIIb
+/tk) or
homozygous deficient embryos (aIIb
tk/tk). Error bars:
standard deviations for n53 independent experiments.
CFU-GEMM: CFU-Granulocyte–Erythroid–
Macrophage–Megakaryocyte; CFU-GM: CFU-
Granulocyte–Macrophage; CFU-M: CFU-Macrophage;
CFU-G: CFU-Granulocyte; BFU-E: Burst-Forming
Unit-Erythroid. (B) Number of c-kit+ cells per E11
aIIb
+/+ (n55 embryos), aIIb
+/tk (n55 embryos) and
aIIb
tk/tk (n53 embryos) aorta. Error bars: standard
deviations. Confocal stack images of the mouse aorta
region of E11 aIIb
+/+ (C) and aIIb
tk/tk (D) embryos after
whole mount staining for c-kit and CD31. Scale bars:
50 mm. ns: not statistically significant. Error bars:
standard deviations.
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Dzierzak, 1996). We tested whether aIIb deficient HSCs can be
maintained and expanded in AGM explant cultures (n53). Cells
from aIIb
+/tk or aIIb
tk/tk AGM explants were able to reconstitute
13% and 20% of the transplanted recipients, as compared to
100% of recipients transplanted with cells from aIIb
+/+ AGM
explants (Fig. 4B). As expected the HSC repopulation ability of
the aIIb
+/+ AGM cells was higher after explant culture, as
compared to transplantations performed without pre-culture
(Fig. 4A). In contrast the HSC repopulation ability of the aIIb
mutant AGM cells was significantly lower. This was not due to
abnormal cycling or increased apoptosis of c-kit+ cells in the aIIb
mutant AGM (supplementary material Fig. S5A,B, respectively).
Altogether, the results support a role for aIIb in the maintenance
of AGM HSC repopulating activity.
aIIb deficient embryos have no major hematopoietic stem cell
defect in the YS or FL
HSC activity of aIIb mutant YSs was also tested (only some YS
HSCs express aIIb). Transplantations with YS cells isolated from
E11 aIIb
+/+, aIIb
+/tk and aIIb
tk/tk embryos (n53) showed similar
percentages of mice reconstituted (28%, 22% and 20%,
respectively) at four months post-transplantation (Fig. 4C).
Thus, while there is a strong HSC defect in the AGM of the
aIIb mutant embryos, it is not the case in the YS.
Similarly, we performed transplantations with FL cells isolated
from E11 aIIb
+/+, aIIb
+/tk and aIIb
tk/tk embryos (n54), at the time
when HSCs start to colonize the FL. The percentage of
reconstituted mice after the injection of aIIb
+/tk or aIIb
tk/tk cells
(25%) was similar to the percentage of reconstituted mice after
the injection of aIIb
+/+ cells (14%) (Fig. 4D) thus showing that
aIIb mutant HSCs are able to migrate and colonize the FL in vivo.
We further tested the HSC activity in the FL of aIIb mutant
embryos at E14, a time point when HSCs extensively expand.
Flow cytometry for Lin2Sca-1+c-kit+CD482CD150+ cells
showed that the absolute numbers of these phenotypically
defined HSCs were similar in aIIb mutant embryos as compared
to wild type (supplementary material Fig. S6). Limiting dilution
transplantation of FL cells (0.001 [n53] and 0.005 [n53] ee per
recipient) (Fig. 5) showed that aIIb mutant FL cells were as
competent as aIIb
+/+ FL cells in recipient reconstitution. Thus,
HSCs have no proliferative defect in the FL of the aIIb mutant
embryos.
Discussion
The aIIb integrin subunit (CD41) is one of the first surface
markers indicative of hematopoietic commitment (Ferkowicz et
al., 2003; McKinney-Freeman et al., 2009; Mikkola et al., 2003;
Robin et al., 2011). It is notably expressed by the first
hematopoietic cells emerging from the hemogenic endothelium
in the aorta (Boisset et al., 2010). We found here that aIIb is not
only a reliable HSC marker, but it also plays an important role in
maintaining HSC activity in the aorta.
We have also found that HSCs differentially express aIIb, b3
and av integrin subunits during ontogeny. Since HSCs in
embryos are difficult to identify in situ, integrin expression can
be used in combination with other markers (as CD45 and c-kit)
to enrich and localize HSCs throughout development.
Surprisingly, a substantial fraction of HSCs in the E11/E12
YS do not express aIIb and/or b3 integrin subunits. Such HSCs
are not detectable in the AGM at the same time point, the YS
might generate such a subset of HSCs. The results of in vivo
CD41-Cre-mediated genetic tagging suggest that all/most HSCs
go through an aIIb expressing phase, as is reflected by a high
percentage of labelled hematopoietic cells in the adult animals
(35–65%) (Rybtsov et al., 2011). Thus, the expression of
integrins on the surface of HSCs appears to not only be
Fig. 4. Functional analyses of AGM, yolk sac and fetal
liver cells isolated from E11 CD41 (aIIb) deficient
embryos. Hematopoietic repopulation analysis of mice
after injection of (A,B) AGM, (C) yolk sac or (D) fetal
liver cells isolated from E11 wild-type (aIIb
+/+),
heterozygous (aIIb
+/tk) or homozygous deficient embryos
(aIIb
tk/tk). (A,B) Percentage of chimerism in peripheral
blood for each injected mice. Lozenge: one transplanted
mouse. Red lozenge: mice used to perform secondary
transplantations. Dashed line: limit of positivity (.10% of
chimerism). Red line: chimerism average. (A) AGM cells
were injected directly (n53) or (B) after explant culture
(n53). The genotype of embryos, the number of mice
repopulated/number of mice transplanted (# Rep./# Inj.)
and the percentage of repopulated mice (% Rep.) are
indicated below the graphs. 1 embryo equivalent (ee) of
AGM cells was injected per recipient (n53). p-values are
indicated. (C,D) Percentage of repopulated mice.
Numbers below columns: number of mice repopulated/
number of mice transplanted. (C) 1 ee of yolk sac cells
(n53) and (D) 3 to 4.5 ee of fetal liver cells (n54) were
injected per recipient. Due to the very low number of
HSCs in E11 FL, aIIb
+/tk and aIIb
tk/tk cells were pooled. ns:
not statistically significant.
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regulated developmentally, but also by the surrounding cells that
compose the HSC niches.
IAHC cells express aIIb (Corbel and Salau¨n, 2002; Yokomizo
and Dzierzak, 2010). Due to low expression levels, the
visualization of CD41 by immunostaining embryo cryosections
is rather difficult and often is in the context of high background.
However, our results show that immunostaining of non-fixed
embryo slices with directly conjugated antibodies allows the
visualization of low level of integrin expression in the aorta with
good resolution (Boisset et al., 2011; Boisset et al., 2010). We
observed that IAHC cells co-express aIIb, b3 and av.
Interestingly, aIIb, b3 and av were mainly localized at the
junction between the cells that form the IAHCs. Using this
improved technique to immunostain viable PL slices, we were
also able to observe the placental vasculature and groups of
HSPCs expressing both av and b3 in the vasculature of the
chorionic plate. Similar to the IAHCs, av and b3 were mainly at
the junctions between the cells.
We have previously shown that hematopoietic progenitors in
the E11 AGM and YS are CD41int, whereas they are in both
CD412 and CD41int fractions in E12 PL and E14 FL (Robin et
al., 2011). To test whether aIIb plays a role in the progenitor
activity in the AGM, we examined a mouse line (aIIb
tk/tk) in
which the aIIb locus was disrupted by the integration of a tk gene,
resulting in the lack of aIIb protein expression (Tronik-Le Roux et
al., 2000). We observed no differences in the total number or
types of progenitors in the AGM of E11 aIIb
+/+, aIIb
+/tk, or aIIb
tk/tk
embryos. Such results indicate that aIIb does not play a role in the
regulation of the hematopoietic progenitors in the AGM region.
This is in contrast to a study in which the disruption of aIIb results
in an increased number of hematopoietic progenitors (CFU-
Myeloid, BFU-E and CFU-Mk) in E9.5 YS, and in E12.5, E13.5
and E15.5 FL (Emambokus and Frampton, 2003). This difference
in the requirement for aIIb on progenitors might depend on the
resident microenvironment. Thus, aIIb does not play a functional
role on the progenitors despite the fact that all progenitors
express this marker in the AGM (Robin et al., 2011).
We observed fewer HSCs and a decrease in the HSC activity in
the AGMs of aIIb mutant embryos. The few remaining HSCs
were found to be functional in transplantation experiments, ruling
out the possibility that aIIb mutant AGM HSCs are defective in
homing to the adult BM niche. Interestingly, we did not find
differences in the HSC activity in aIIb mutant YS and FL at the
same time point of development (E11). The HSC activity was
also normal at a later stage (E14), when HSC expansion occurs in
the FL, indicating that aIIb mutant HSCs can undergo normal
expansion. The HSC defect is thus restricted to the AGM region.
The HSC activity was also lower after explant culture of the aIIb
mutant AGMs showing that HSC activity is not maintained in the
AGM when aIIb is absent. The defect seems to be cell intrinsic since
only IAHC cells (where HSCs reside) express aIIb in the aorta at this
stage of development. The observation that the HSC defect is similar
in the AGMs in both aIIb
+/tk and aIIb
tk/tk embryos suggests that a
certain threshold of aIIb on the surface of HSCs might therefore be
necessary to maintain the HSC activity in the AGM.
We found in aIIb mutant embryos that the number of c-kit
+
IAHC cells and the shape of the IAHCs are similar to that in
wild-type embryos. Thus, either aIIb does not play a role in IAHC
cell anchorage, or other adhesion molecules compensate for the
absence of aIIb (e.g. avb3). The normal number of IAHCs also
shows that aIIb, which is expressed by the emerging IAHCs and
HSCs, is not required for the endothelial to hematopoietic
transition (EHT).
Integrin binding to extra-cellular matrix compounds induces
outside-in signaling through clustering of integrin heterodimers at
focal adhesion sites (Gong et al., 2010; Hynes, 2002). This will
recruit other cell surface receptors and many proteins that will
activate intracellular signaling pathways. Therefore, the absence
of aIIb might have direct or indirect consequences, resulting for
example in the lack of recruitment of important receptors to the
focal adhesion points (e.g. cytokine receptors) or the lack of
signaling downstream of aIIbb3 integrins. It was shown that
platelet clot formation is mediated through phosphorylation of
the c-Src kinase (regulating downstream effectors such as RhoA)
after binding of aIIbb3 to the Ga13 subunit (Gong et al., 2010). It
was also recently shown that outside-in signaling via pY747 of b3
(b3PY747) following activation of avb3 integrin by TPO-
mediated inside-out signaling is indispensable for TPO-
mediated maintenance of HSC activity in vitro and in vivo
within the BM niche (Umemoto et al., 2012). Whether such
mechanisms are also active on E11 AGM HSCs will be the focus
of further investigations.
Altogether our study shows that b3 and av integrin subunits, in
addition to aIIb, are reliable markers of the first HSCs found in
the AGM. Such subunits are then differentially expressed by
HSCs throughout embryonic development and can be used to
isolate and localize HSCs. It has been shown that some integrin
subunits are important for the retention of HSPCs in the adult BM
Fig. 5. Functional analyses of E14 fetal liver
cells isolated from CD41 (aIIb) deficient
embryos. Hematopoietic repopulation analysis
of mice after the injection of fetal liver cells
isolated from E14 wild-type (aIIb
+/+; grey bars),
heterozygous (aIIb
+/tk; dark grey bars), or
homozygous deficient (aIIb
tk/tk; black bars
embryos. Numbers above columns: number of
mice repopulated/number of mice transplanted.
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niches (e.g. a4 (Scott et al., 2003)) and/or for the colonization of
HSPCs into the FL and BM (e.g. b1 (Hirsch et al., 1996; Potocnik
et al., 2000)). Here we highlight a new role for integrin subunits
and provide evidence that aIIb is important to maintain the HSC
activity in the aorta.
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